Published in Exp Mol Pathol on January 30, 2007
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res (2010) 0.89
Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? ScientificWorldJournal (2012) 0.83
Circulating matrix metalloproteinases in children with diabetic ketoacidosis. Pediatr Diabetes (2016) 0.75
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica. Acta Neuropathol (2017) 0.75
Complement and Humoral Adaptive Immunity in the Human Choroid Plexus: Roles for Stromal Concretions, Basement Membranes, and Epithelium. J Neuropathol Exp Neurol (2016) 0.75
Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr (2004) 2.15
The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child (2001) 1.86
The choroid plexus in the rise, fall and repair of the brain. Bioessays (2005) 1.61
Pathophysiology of brain edema formation. Neurosurg Clin N Am (2002) 1.50
Fatal Diabetic Ketosis. Br Med J (1961) 1.46
Choroid plexus: target for polypeptides and site of their synthesis. Microsc Res Tech (2001) 1.44
Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J Exp Biol (2004) 1.39
Intracerebral administration of interleukin-1beta and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg (2000) 1.36
Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery (2006) 1.35
Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol (1999) 1.31
Overexpression of inducible heat shock protein 70 and its mutants in astrocytes is associated with maintenance of mitochondrial physiology during glucose deprivation stress. Cell Stress Chaperones (2006) 1.27
Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR Am J Neuroradiol (1988) 1.23
Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol Scand (2001) 1.15
Correlates of brain edema in uncontrolled IDDM. Diabetes (1992) 1.12
Diabetic ketoacidosis promotes a prothrombotic state. Endocr Res (2003) 1.12
Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke (2005) 1.10
Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol Res (2004) 1.09
The complement system in central nervous system diseases. Autoimmunity (2006) 1.00
Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest (1999) 0.99
Expression of the bumetanide-sensitive Na-K-Cl cotransporter BSC2 is differentially regulated by fluid mechanical and inflammatory cytokine stimuli in vascular endothelium. J Clin Invest (1997) 0.99
Expression of interleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides. Cytokine (2000) 0.98
Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1beta and nerve growth factor in cultured hippocampal neuronal cells. Brain Res (2004) 0.96
C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis. Exp Mol Pathol (2004) 0.96
Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabetes Complications (1999) 0.96
Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience (2000) 0.96
Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol (2003) 0.96
Diabetic ketoacidosis increases extracellular levels of the major inducible 70-kDa heat shock protein. Clin Biochem (2005) 0.95
Heat shock treatment protects osmotic stress-induced dysfunction of the blood-brain barrier through preservation of tight junction proteins. Cell Stress Chaperones (2004) 0.94
Intracerebroventricular injection of the terminal complement complex causes inflammatory reaction in the rat brain. Eur J Immunol (2003) 0.92
T cells and autoantibodies to human HSP70 in type 1 diabetes in children. J Autoimmun (2003) 0.92
Pro-inflammatory cytokines modulate matrix metalloproteinase secretion and organic anion transport at the blood-cerebrospinal fluid barrier. J Neuropathol Exp Neurol (2003) 0.91
Differential regulation of endothelial cell activation by complement and interleukin 1alpha. Circ Res (2006) 0.89
The choroid plexus response to peripheral inflammatory stimulus. Neuroscience (2006) 0.89
Recent insights into the regulation of cerebral circulation. Clin Exp Pharmacol Physiol (1996) 0.87
Delayed profound local brain hypothermia markedly reduces interleukin-1beta gene expression and vasogenic edema development in a porcine model of intracerebral hemorrhage. Acta Neurochir Suppl (2006) 0.86
Relative contributions of a CVO and the microvascular bed to delivery of blood-borne IL-1alpha to the brain. Am J Physiol (1998) 0.86
Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci Lett (2002) 0.85
Elevated levels of inducible heat shock 70 proteins in human brain. Neurobiol Aging (2006) 0.85
Contribution of heat shock proteins to cell protection from complement-mediated lysis. Int Immunol (2001) 0.84
Complement activation in diabetic ketoacidosis and its treatment. Clin Immunol (2005) 0.83
Complement activation in diabetic ketoacidosis brains. Exp Mol Pathol (2006) 0.82
Expression of nitric oxide synthases and nitrotyrosine during blood-brain barrier breakdown and repair after cold injury. Lab Invest (2001) 0.82
Computer analysis of magnetic resonance imaging of the brain in children and adolescents after treatment of diabetic ketoacidosis. J Diabetes Complications (2000) 0.81
Intracerebral administration of neuronal nitric oxide synthase antiserum attenuates traumatic brain injury-induced blood-brain barrier permeability, brain edema formation, and sensory motor disturbances in the rat. Acta Neurochir Suppl (2006) 0.78
Involvement of interleukin-1beta/nitric oxide pathway in the postischemic impairment of long-term potentiation of the rat hippocampus. Neurosci Lett (2001) 0.77
Interleukin-1 and the constellation of pulmonary oedema, and cerebral infarctions and oedema in diabetic ketoacidosis. Diabet Med (2006) 0.76
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. Diabet Med (2002) 0.76
Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol (2012) 2.52
The minicolumn hypothesis in neuroscience. Brain (2002) 2.03
Microvascular brain pathology and late-life motor impairment. Neurology (2013) 1.64
Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology (2013) 1.51
Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation. J Biol Chem (2006) 1.31
Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol (2007) 1.31
Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke (2011) 1.30
Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res (2011) 1.28
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J Biol Chem (2001) 1.23
Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Cardiovasc Res (2004) 1.21
Reduced temporal lobe volume in early onset conduct disorder. Psychiatry Res (2004) 1.19
RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells. J Biol Chem (2009) 1.18
Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown. Lab Invest (2005) 1.15
Auditory cortex asymmetry, altered minicolumn spacing and absence of ageing effects in schizophrenia. Brain (2008) 1.13
C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J Biol Chem (2006) 1.11
Overexpression of RGC-32 in colon cancer and other tumors. Exp Mol Pathol (2005) 1.10
White matter volume increase and minicolumns in autism. Ann Neurol (2004) 1.09
Effects of low frequency repetitive transcranial magnetic stimulation (rTMS) on gamma frequency oscillations and event-related potentials during processing of illusory figures in autism. J Autism Dev Disord (2008) 1.09
Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest (2003) 1.07
The role of complement activation in atherosclerosis. Immunol Res (2004) 1.07
Event-related potential study of novelty processing abnormalities in autism. Appl Psychophysiol Biofeedback (2009) 1.05
The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol Res (2005) 1.04
Social, communication, and cortical structural impairments in Epac2-deficient mice. J Neurosci (2012) 1.02
Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown. Acta Neuropathol (2008) 1.02
Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system. Ann Neurol (2006) 1.00
Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am J Pathol (2003) 0.99
C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP. J Immunol (2006) 0.99
Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp Mol Pathol (2009) 0.98
The minicolumn and evolution of the brain. Brain Behav Evol (2002) 0.97
Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp Mol Pathol (2005) 0.97
Role of response gene to complement 32 in diseases. Arch Immunol Ther Exp (Warsz) (2008) 0.96
C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis. Exp Mol Pathol (2004) 0.96
Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related potential measures of novelty processing in autism. Appl Psychophysiol Biofeedback (2010) 0.96
Identification of myo-inositol-3-phosphate synthase isoforms: characterization, expression, and putative role of a 16-kDa gamma(c) isoform. J Biol Chem (2009) 0.95
Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry (2013) 0.95
Epigenetic modifications induced by RGC-32 in colon cancer. Exp Mol Pathol (2009) 0.94
Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease. Mov Disord (2012) 0.92
Autism and dyslexia: a spectrum of cognitive styles as defined by minicolumnar morphometry. Med Hypotheses (2009) 0.91
Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Modulates Evoked-Gamma Frequency Oscillations in Autism Spectrum Disorder (ASD). J Neurother (2010) 0.91
Above genetics: lessons from cerebral development in autism. Transl Neurosci (2011) 0.90
Prefrontal neuromodulation using rTMS improves error monitoring and correction function in autism. Appl Psychophysiol Biofeedback (2012) 0.90
Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. J Immunol (2004) 0.89
Minicolumn thinning in temporal lobe association cortex but not primary auditory cortex in normal human ageing. Acta Neuropathol (2006) 0.89
Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement. J Rehabil Res Dev (2006) 0.89
Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Ann N Y Acad Sci (2003) 0.89
Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes. J Neuroimmunol (2003) 0.87
IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms. J Immunol (2012) 0.86
A 40-year-old male with an intraventricular tumor. Combined tanycytic ependymoma and subependymoma. Brain Pathol (2013) 0.86
Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis. Exp Mol Pathol (2007) 0.86
Impaired Error Monitoring and Correction Function in Autism. J Neurother (2010) 0.86
Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Arthritis Rheum (2003) 0.85
Magnetic resonance imaging findings for dyslexia: a review. J Biomed Nanotechnol (2014) 0.83
Complement activation in diabetic ketoacidosis brains. Exp Mol Pathol (2006) 0.82
Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer. Immunol Res (2013) 0.82
Dual role of Response gene to complement-32 in multiple sclerosis. Exp Mol Pathol (2012) 0.82
Extracellular hsp70 release in canine Steroid Responsive Meningitis-Arteritis. Vet Immunol Immunopathol (2011) 0.82
Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis. J Neuroimmunol (2008) 0.82
C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation. Exp Mol Pathol (2011) 0.81
B-cells and humoral immunity in multiple sclerosis. Implications for therapy. Immunol Res (2008) 0.81
Differential expression of methyl CpG-binding domain containing factor MBD3 in the developing and adult rat brain. J Neurobiol (2003) 0.81
TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects. Clin Immunol (2009) 0.81
Muscle and nerve involvement in granulomatous mycosis fungoides. Muscle Nerve (2007) 0.81
Early-stage visual processing abnormalities in high-functioning autism spectrum disorder (ASD). Transl Neurosci (2010) 0.81
A rare intramedullary spinal cord metastasis from uterine leiomyosarcoma. J Clin Neurosci (2013) 0.81
Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis. Cell Rep (2015) 0.81
EVENT-RELATED POTENTIAL STUDY OF ATTENTION REGULATION DURING ILLUSORY FIGURE CATEGORIZATION TASK IN ADHD, AUTISM SPECTRUM DISORDER, AND TYPICAL CHILDREN. J Neurother (2012) 0.80
Differential methylation of the gene encoding myo-inositol 3-phosphate synthase (Isyna1) in rat tissues. Epigenomics (2011) 0.80
JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells. J Peripher Nerv Syst (2006) 0.80
Shape analysis of the human brain: a brief survey. IEEE J Biomed Health Inform (2014) 0.79
FLT-3 expression and function on microglia in multiple sclerosis. Exp Mol Pathol (2010) 0.79
The need for veterinarians in biomedical research. J Vet Med Educ (2009) 0.79
INDUCED EEG GAMMA OSCILLATION ALIGNMENT IMPROVES DIFFERENTIATION BETWEEN AUTISM AND ADHD GROUP RESPONSES IN A FACIAL CATEGORIZATION TASK. J Neurother (2012) 0.79
Neuromodulation integrating rTMS and neurofeedback for the treatment of autism spectrum disorder: an exploratory study. Appl Psychophysiol Biofeedback (2014) 0.78
Role of SIRT1 in autoimmune demyelination and neurodegeneration. Immunol Res (2015) 0.78
Gyral window mapping of typical cortical folding using MRI. Transl Neurosci (2011) 0.78
Shape modeling of the corpus callosum. Conf Proc IEEE Eng Med Biol Soc (2010) 0.78
Mammalian inositol 3-phosphate synthase: its role in the biosynthesis of brain inositol and its clinical use as a psychoactive agent. Subcell Biochem (2006) 0.78
Autism or autisms? Finding the lowest common denominator. Bol Asoc Med P R (2011) 0.78
Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival. J Neuroimmunol (2009) 0.77
Angiopoietins are expressed in the normal rat pituitary gland. Endocr Pathol (2005) 0.77
Spherical harmonic analysis of cortical complexity in autism and dyslexia. Transl Neurosci (2012) 0.77
Accurate automated detection of autism related corpus callosum abnormalities. J Med Syst (2010) 0.77
Autism diagnostics by 3D texture analysis of cerebral white matter gyrifications. Med Image Comput Comput Assist Interv (2007) 0.77
Chronic (Rasmussen's) encephalitis in an adult. Can J Neurol Sci (2003) 0.76
The importance of using equimolar DNA for transfection analysis of the 5' flanking promoter regions of genes. Anal Biochem (2005) 0.76
Dyslexia diagnostics by 3-D shape analysis of the corpus callosum. IEEE Trans Inf Technol Biomed (2012) 0.76
Detection of multiple proteins in intracerebral vessels by confocal microscopy. Methods Mol Biol (2011) 0.76
Cerebral vascular hamartoma in a geriatric cat. J Feline Med Surg (2011) 0.75
Involvement of the choroid plexus in the inflammatory response after acute spinal cord injury in dogs: an immunohistochemical study. Vet Immunol Immunopathol (2012) 0.75
Association of complement inhibitors with connective tissue matrix in atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2003) 0.75
A suprasellar germ cell tumor in a 16-month-old Wagyu heifer calf. J Vet Diagn Invest (2012) 0.75
Reduced levels of nitric oxide metabolites in cerebrospinal fluid are associated with equine protozoal myeloencephalitis. Clin Diagn Lab Immunol (2002) 0.75
Proteomic analysis of rat prefrontal cortex after chronic valproate treatment. J Neurosci Res (2014) 0.75
MRI features of gliomatosis cerebri in a dog. Vet Radiol Ultrasound (2012) 0.75